Both in Pharmaceuticals
Lifecore Biomedical vs Immuneering
Over the past year LFCR returned −10.0% and IMRX returned −46.3%; their daily moves had a correlation of 0.05.
LFCR −10.0% IMRX −46.3%Growth of $1, one year, split-adjusted
| Metric | LFCR | IMRX |
|---|---|---|
| Price | $6.40 | $3.52 |
| Market cap | $242.6M | $228.0M |
| Today | 0.00% | −6.01% |
| 1 month | −2.1% | −13.5% |
| 6 months | +24.8% | −34.6% |
| Year to date | −21.8% | −46.5% |
| 1 year | −9.9% | −45.1% |
| Revenue growth (YoY) | — | — |
| Gross margin | 35.3% | — |
| Net margin | −20.9% | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | -$136.9M | $145.4M |
| Dividend yield | — | — |
| Volatility (60d) | 98.2% | 52.1% |
| Short % of float | 6.5% | 29.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).